Patents by Inventor Jingfang Zhang

Jingfang Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD AND SYSTEM FOR PROVIDING A CONTEXT-SENSITIVE, NON-INTRUSIVE DATA PROCESSING OPTIMIZATION FRAMEWORK
    Publication number: 20230004563
    Abstract: A method of performing a data search in a data source by which an operator of a data search pipeline is just-in-time optimized and compiled, using an operator optimization module which optimizes and compiles an intermediate representation of the operator, considering runtime information, and optimization rules, to produce an operator that is optimized for the data search being performed. The method can be applied with one operator or with many operators applied in any sequence or tree structure according to a query plan, as determined by runtime information and optimization rules.
    Type: Application
    Filed: August 8, 2022
    Publication date: January 5, 2023
    Inventors: Zanqing ZHANG, Benoit HUDZIA, Arven DING, Guo YANG, Zheng LI, Jingfang ZHANG, Songling LIU, Denghong LIAO
  • Substituted penta-fused hexa-heterocyclic compounds, preparation method therefor, drug combination and use thereof
    Patent number: 11352354
    Abstract: A type of substituted penta-fused hexa-heterocyclic compounds having selective inhibition for PIKfyve kinase, a pharmaceutically acceptable salt and pharmaceutically acceptable solvate thereof, a method for the preparation thereof, a pharmaceutical composition comprising the same, and use of these compounds in the manufacture of a medicament for preventing or treating a disease associated with PIKfyve in vivo, in particular in the manufacture of a medicament for preventing or treating tumor growth and metastasis.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: June 7, 2022
    Assignee: Xiamen University
    Inventors: Xianming Deng, Wei Huang, Xihuan Sun, Ting Zhang, Zhixiang He, Yan Liu, Xinrui Wu, Baoding Zhang, Xiaoyang Li, Jingfang Zhang, Yun Chen, Li Li, Qingyan Xu, Zhiyu Hu
  • Substituted aryl ether compound, preparation method thereof, pharmaceutical composition and use thereof
    Patent number: 11319322
    Abstract: The present invention relates to a compound having the following formula, or a stereoisomer thereof, a prodrug thereof, a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable solvate thereof, preparation method thereof, pharmaceutical composition comprising the same and use of the compound in the manufacture of a medicament for preventing or treating tumor, wherein the substituents are as defined in the specification.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: May 3, 2022
    Assignee: Xiamen University
    Inventors: Xianming Deng, Ting Zhang, Qiaofeng Kang, Yanru Yang, Xihuan Sun, Zaiyou Yang, Xiaoyang Li, Jingfang Zhang, Jiaji Zhong, Zhou Deng, Chao Dong, Shuang Liu, Li Li, Qingyan Xu, Zhiyu Hu
  • SUBSTITUTED PENTA-FUSED HEXA-HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, DRUG COMBINATION AND USE THEREOF
    Publication number: 20200165246
    Abstract: A type of substituted penta-fused hexa-heterocyclic compounds having selective inhibition for PIKfyve kinase, a pharmaceutically acceptable salt and pharmaceutically acceptable solvate thereof, a method for the preparation thereof, a pharmaceutical composition comprising the same, and use of these compounds in the manufacture of a medicament for preventing or treating a disease associated with PIKfyve in vivo, in particular in the manufacture of a medicament for preventing or treating tumor growth and metastasis.
    Type: Application
    Filed: August 3, 2018
    Publication date: May 28, 2020
    Applicant: Xiamen University
    Inventors: Xianming Deng, Wei Huang, Xihuan Sun, Ting Zhang, Zhixiang He, Yan Liu, Xinrui Wu, Baoding Zhang, Xiaoyang Li, Jingfang Zhang, Yun Chen, Li Li, Qingyan Xu, Zhiyu Hu
  • SUBSTITUTED ARYL ETHER COMPOUND, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF
    Publication number: 20200123162
    Abstract: The present invention relates to a compound having the following formula, or a stereoisomer thereof, a prodrug thereof, a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable solvate thereof, preparation method thereof, pharmaceutical composition comprising the same and use of the compound in the manufacture of a medicament for preventing or treating tumor, wherein the substituents are as defined in the specification.
    Type: Application
    Filed: June 29, 2018
    Publication date: April 23, 2020
    Applicant: Xiamen University
    Inventors: Xianming Deng, Ting Zhang, Qiaofeng Kang, Yanru Yang, Xihuan Sun, Zaiyou Yang, Xiaoyang Li, Jingfang Zhang, Jiaji Zhong, Zhou Deng, Chao Dong, Shuang Liu, Li Li, Qingyan Xu, Zhiyu Hu